Ray continued, “We’re also delighted to recognize Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology had been instrumental to shaping the development of STK-012, our initial-in-class alpha/beta biased IL-two. Its unique system expands the therapeutic index of IL-two, one of https://finnzkudm.losblogos.com/35679064/not-known-factual-statements-about-https-www-zosanopharma-com-technology